Teladoc Health, Inc. (LON:0LDR)
London · Delayed Price · Currency is GBP · Price in USD 4.532
-0.058 (-1.27%)
Feb 12, 2026, 5:09 PM GMT
Teladoc Health Market Cap
Teladoc Health has a market cap or net worth of 608.75 million as of February 12, 2026. Its market cap has decreased by -58.20% in one year.
Market Cap
608.75M
Enterprise Value
840.22M
Revenue
1.88B
Ranking
n/a
PE Ratio
n/a
Stock Price
4.53
Market Cap Chart
Since July 1, 2015, Teladoc Health's market cap has decreased from 675.25M to 608.75M, a decrease of -9.85%. That is a compound annual growth rate of -0.97%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 608.75M | -34.05% |
| Dec 31, 2025 | 923.04M | -26.16% |
| Dec 31, 2024 | 1.25B | -55.37% |
| Dec 29, 2023 | 2.80B | -11.87% |
| Dec 30, 2022 | 3.18B | -70.72% |
| Dec 31, 2021 | 10.86B | -48.87% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 215.40B |
| GSK plc | 87.00B |
| Haleon | 35.66B |
| Smith & Nephew | 10.94B |
| Oxford Biomedica | 1.00B |
| CVS Group | 977.97M |
| Spire Healthcare Group | 814.80M |
| Allergy Therapeutics | 718.55M |